FDA · Drug approval ·
FDA approves dapagliflozin and metformin extended-release tablets
The FDA approved dapagliflozin and metformin extended-release tablets for adults with type 2 diabetes.
If you have type 2 diabetes, the Food and Drug Administration (FDA) has approved dapagliflozin and metformin hydrochloride extended-release tablets. The tablet is meant to work alongside diet and exercise to improve blood sugar control.
The label also includes dapagliflozin’s added benefits in certain conditions, including chronic kidney disease and heart failure, to help reduce risks such as kidney decline, cardiovascular death, and hospitalization for heart failure.
This product contains metformin and dapagliflozin; it is not recommended for people with type 1 diabetes, and it is limited to type 2 diabetes for all uses described on the label.
What we explain about this
Amitriptyline hydrochloride overdoseLearn how amitriptyline overdose affects the heart, brain, and breathing, and why suspected poisoning requires immediate medical care.Antidiarrheal medicine overdoseLearn how antidiarrheal medicine overdose can affect breathing, heart rhythm, and other body systems, and when to contact Poison Control or seek emergency care.